Floatz logo

Car-20/19-T Cells

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Medical College of WisconsinCell therapyPhase 1/2Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Primary Mediastinal Large B-cell Lymphoma (PMBCL) cohort.

Asset / SponsorPhaseRating
Epirubicin
Seda S. Tolu
Phase 2BB
Pembrolizumab
Seda S. Tolu
Phase 2BB
Wztl-002 Car T-Cells
Malaghan Institute of Medical Research
Phase 2CCC
VNX-101
Vironexis Biotherapeutics Inc.
Phase 1/2CC
tc011
TICAROS Co., Ltd.
Phase 1/2CC

View all 13 →

Same molecule, other indications

Car-20/19-T Cells is also rated in:

non-Hodgkin lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CC
Indicative ·
45 / 100
View asset →
Mantle Cell Lymphoma (MCL)Dormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →